These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 314310)

  • 21. [Membrane markers of lymphoid cells in immunoproliferative diseases of man].
    Seligmann M; Brouet JC; Preud'homme JL
    Z Gesamte Inn Med; 1980 Jan; 35(2):66-9. PubMed ID: 6996351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sézary syndrome: a model for migration of T lymphocytes to skin.
    Miller RA; Coleman CN; Fawcett HD; Hoppe RT; McDougall IR
    N Engl J Med; 1980 Jul; 303(2):89-92. PubMed ID: 6966761
    [No Abstract]   [Full Text] [Related]  

  • 23. T cells in cutaneous lesions of Sézary syndrome and T-cell leukemia. Characterization by monoclonal antibodies.
    Buechner SA; Winkelmann RK; Banks PM
    Arch Dermatol; 1983 Nov; 119(11):895-900. PubMed ID: 6227293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of Sezary's syndrome with terminal "leukemic phase".
    Specchia G; Tursi A; Liso V; Errico G; Bonomo L
    Haematologica; 1981 Jun; 66(3):279-88. PubMed ID: 6793457
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
    Thivolet J; Souteyrand P; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(6):357-64. PubMed ID: 363474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Living Sézary cells in vitro: formation of autologous rosettes (author's transl)].
    Bauer R; Schütz R
    Arch Dermatol Res; 1980; 269(3):261-8. PubMed ID: 7235732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sézary's syndrome with an unusual immunologic picture].
    Sakalová A; Hrubisko M; Jakubovský J; Abelovic M
    Vnitr Lek; 1980 Oct; 26(10):974-81. PubMed ID: 6970448
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sezary syndrome with serum monoclonal immunoglobulin. Absence of detectable shared idiotype between the monoclonal immunoglobulin and membrane structures of the Sezary cells (author's transl)].
    Preud'homme JL; Sohier J; Danon F
    Nouv Presse Med; 1980 Mar; 9(17):1215-7. PubMed ID: 7005868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructure and cell marker studies in lymphoproliferative disorders.
    Catovsky D; Costello C; O'Brien M; Cherchi M
    Haematol Blood Transfus; 1979; 23():107-13. PubMed ID: 317469
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sézary syndrome: morpho-immuno-phenotypic, cytogenetic and molecular characterization].
    Benítez J; Santos M; Rivas C; Martínez Castro P; Castro A
    Med Clin (Barc); 1989 Jun; 93(3):103-7. PubMed ID: 2796429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restricted TRBC1 expression: A clonality marker for circulating Sézary cells.
    Tintle S; Fuda F; Chen W
    Am J Hematol; 2021 Oct; 96(10):1338-1339. PubMed ID: 34342917
    [No Abstract]   [Full Text] [Related]  

  • 34. [Re-expression of the sheep red blood cell receptor--a diagnostic marker of cutaneous T-cell lymphomas?].
    Westphal HJ; Schröder I
    Dermatol Monatsschr; 1989; 175(2):87-94. PubMed ID: 2785938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome markers and evidence for clone formation in lymphocytes of a patient with Sézary syndrome.
    Liang JC; Gaulden ME; Herndon JH
    Cancer Res; 1980 Oct; 40(10):3426-9. PubMed ID: 6934025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurolymphomatosis associated with Sézary syndrome.
    Bezier M; Reguiaï Z; Delaby P; Laroche L; Saïd G; Bernard P; Grange F
    Arch Dermatol; 2009 Mar; 145(3):294-6. PubMed ID: 19289760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sézary syndrome: infiltration of the gastric wall--does it matter?
    Schuler MK; Kroschinsky F; Schaich M; Kalauch A; Stroszczynski C; Kellermann S; Ehninger G; Benter T
    Ann Hematol; 2012 Sep; 91(9):1507-9. PubMed ID: 22362119
    [No Abstract]   [Full Text] [Related]  

  • 38. CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry.
    Bahler DW; Hartung L; Hill S; Bowen GM; Vonderheid EC
    Cytometry B Clin Cytom; 2008 May; 74(3):156-62. PubMed ID: 18061949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kinetics of Sézary cell production.
    Shackney SE; Edelson R; Bunn PA
    Cancer Treat Rep; 1979 Apr; 63(4):659-61. PubMed ID: 445517
    [No Abstract]   [Full Text] [Related]  

  • 40. Sezary syndrome in a patient with multiple myeloma: demonstration of a clonally distinct second malignancy.
    Cartron G; Roingeard P; Benboubker L; Vaillant L; Tartas S; Delain M; Lefranc T; Brémond JL; Bout M; Linassier C; Colombat P
    Eur J Haematol; 1999 Nov; 63(5):354-7. PubMed ID: 10580568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.